GlassScriptPhysician profile
Rami S Eltibi
NPI 1932214194
$5,336.31
in general payments reported to CMS, 2019-2025
26 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $37.29 · 2021: $721 · 2022: $864 · 2023: $531 · 2024: $1,098 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,235.98 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $644.32 | 2021-2025 | Farxiga, Wainua |
| Medtronic, INC. | $472.48 | 2021-2025 | Corevalve Evolut R, Spiderfx, Hawkone |
| Novartis Pharmaceuticals Corporation | $470.55 | 2019-2025 | |
| Abbott Laboratories | $400.50 | 2020-2025 | Diamondback Coronary, Xience Skypoint, Optis |
| E.R. Squibb & Sons, L.L.C. | $384.10 | 2022-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $316.37 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $191.21 | 2025 | |
| Boston Scientific Corporation | $184.51 | 2023-2025 | Avvigo Guidance System, Watchman Access System, Ranger |
| Shockwave Medical, INC | $183.25 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $172.84 | 2021-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $112.07 | 2022-2023 | |
| Surmodics, INC. | $101.93 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Abiomed | $77.38 | 2024 | Impella |
| Esperion Therapeutics, INC. | $74.28 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.31 | 2022-2024 | Verquvo |
| Novo Nordisk INC | $43.33 | 2025 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $35.38 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $25.34 | 2020 | |
| Scpharmaceuticals INC. | $25.33 | 2025 | |
| W. L. Gore & Associates, INC. | $22.87 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cardiovascular Systems INC. | $21.83 | 2021 | |
| Cook Medical LLC | $20.51 | 2021 | |
| Pfizer INC. | $18.90 | 2025 | |
| Lantheus Medical Imaging, INC. | $18.71 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Eltibi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.